BioMarin Pharmaceutical Shares Outstanding 2006-2019 | BMRN

BioMarin Pharmaceutical shares outstanding history from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • BioMarin Pharmaceutical shares outstanding for the quarter ending September 30, 2019 were 0.186B, a 4.76% increase year-over-year.
  • BioMarin Pharmaceutical 2018 shares outstanding were 0.177B, a 1.63% increase from 2017.
  • BioMarin Pharmaceutical 2017 shares outstanding were 0.174B, a 4.94% increase from 2016.
  • BioMarin Pharmaceutical 2016 shares outstanding were 0.166B, a 3.87% increase from 2015.
BioMarin Pharmaceutical Annual Shares Outstanding
(Millions of Shares)
2018 177
2017 174
2016 166
2015 160
2014 146
2013 138
2012 120
2011 112
2010 126
2009 100
2008 104
2007 96
2006 85
2005 69
BioMarin Pharmaceutical Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 186
Q2 2019 179
Q1 2019 178
Q4 2018 177
Q3 2018 177
Q2 2018 177
Q1 2018 176
Q4 2017 174
Q3 2017 175
Q2 2017 174
Q1 2017 173
Q4 2016 166
Q3 2016 168
Q2 2016 163
Q1 2016 162
Q4 2015 160
Q3 2015 161
Q2 2015 160
Q1 2015 158
Q4 2014 146
Q3 2014 159
Q2 2014 146
Q1 2014 144
Q4 2013 138
Q3 2013 141
Q2 2013 140
Q1 2013 128
Q4 2012 120
Q3 2012 123
Q2 2012 118
Q1 2012 115
Q4 2011 112
Q3 2011 112
Q2 2011 111
Q1 2011 111
Q4 2010 126
Q3 2010 131
Q2 2010 102
Q1 2010 104
Q4 2009 100
Q3 2009 102
Q2 2009 101
Q1 2009 100
Q4 2008 104
Q3 2008 103
Q2 2008 104
Q1 2008 104
Q4 2007 96
Q3 2007 96
Q2 2007 96
Q1 2007 95
Q4 2006 85
Q3 2006 86
Q2 2006 85
Q1 2006 75
Q4 2005 69
Q3 2005 72
Q2 2005 65
Q1 2005 65
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $15.963B $1.491B
BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.614B 16.54
CSL (CSLLY) Australia $93.536B 0.00
Gilead Sciences (GILD) United States $81.096B 10.05
Vertex Pharmaceuticals (VRTX) United States $60.212B 61.46
Biogen (BIIB) United States $52.886B 9.08
Illumina (ILMN) United States $47.097B 51.68
Regeneron Pharmaceuticals (REGN) United States $42.902B 18.79
Alexion Pharmaceuticals (ALXN) United States $24.902B 12.30
Seattle Genetics (SGEN) United States $18.278B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Incyte (INCY) United States $17.348B 40.27
Genmab (GNMSF) Denmark $14.195B 62.70
Alnylam Pharmaceuticals (ALNY) United States $13.166B 0.00
Galapagos (GLPG) Belgium $11.944B 30.77
Exact Sciences (EXAS) United States $11.645B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.484B 55.12
BeiGene (BGNE) Cayman Islands $10.078B 0.00
Sarepta Therapeutics (SRPT) United States $9.709B 0.00
Bio-Techne Corp (TECH) United States $8.396B 56.20
BioNTech SE (BNTX) Germany $7.817B 0.00
QIAGEN (QGEN) Netherlands $7.661B 24.98
Guardant Health (GH) United States $7.568B 0.00
Horizon Therapeutics Public (HZNP) Ireland $7.069B 17.97
ACADIA Pharmaceuticals (ACAD) United States $6.993B 0.00
Amarin (AMRN) Ireland $6.930B 0.00
Moderna (MRNA) United States $6.745B 0.00
Reata Pharmaceuticals (RETA) United States $6.431B 0.00
Exelixis (EXEL) United States $6.197B 17.43
Ascendis Pharma (ASND) Denmark $5.865B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.816B 0.00
Bluebird Bio (BLUE) United States $5.186B 0.00
Repligen (RGEN) United States $5.185B 93.96
China Biologic Products (CBPO) China $4.609B 25.97
MorphoSys AG (MOR) Germany $4.179B 0.00
Blueprint Medicines (BPMC) United States $3.949B 0.00
Mirati Therapeutics (MRTX) United States $3.866B 0.00
Immunomedics (IMMU) United States $3.784B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.694B 0.00
Adaptive Biotechnologies (ADPT) United States $3.682B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.523B 0.00
MyoKardia (MYOK) United States $3.517B 0.00
NeoGenomics (NEO) United States $3.382B 179.97
CRISPR Therapeutics AG (CRSP) Switzerland $3.288B 0.00
Alkermes (ALKS) Ireland $3.150B 0.00
UniQure (QURE) Netherlands $3.034B 0.00
Zai Lab (ZLAB) China $3.006B 0.00
Genmab (GMAB) Denmark $2.971B 6.12
Halozyme Therapeutics (HALO) United States $2.965B 0.00
Acceleron Pharma (XLRN) United States $2.884B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.862B 0.00
Emergent Biosolutions (EBS) United States $2.837B 28.18
Amicus Therapeutics (FOLD) United States $2.647B 0.00
Epizyme (EPZM) United States $2.382B 0.00
Arena Pharmaceuticals (ARNA) United States $2.264B 5.27
RA PHARMCTL INC (RARX) United States $2.216B 0.00
Myriad Genetics (MYGN) United States $2.183B 32.25
Insmed (INSM) United States $2.134B 0.00
Denali Therapeutics (DNLI) United States $1.977B 0.00
Fate Therapeutics (FATE) United States $1.850B 0.00
Principia Biopharma (PRNB) United States $1.811B 0.00
REGENXBIO (RGNX) United States $1.752B 0.00
Arvinas (ARVN) United States $1.742B 0.00
Zymeworks (ZYME) Canada $1.732B 0.00
Akcea Therapeutics (AKCA) United States $1.717B 0.00
Editas Medicine (EDIT) United States $1.682B 0.00
Ligand Pharmaceuticals (LGND) United States $1.602B 30.82
Orchard Therapeutics (ORTX) United Kingdom $1.482B 0.00
Intra-Cellular Therapies (ITCI) United States $1.460B 0.00
Innoviva (INVA) United States $1.458B 4.30
Dicerna Pharmaceuticals (DRNA) United States $1.395B 0.00
Coherus BioSciences (CHRS) United States $1.389B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.352B 0.00
Alector (ALEC) United States $1.303B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.195B 0.00
DBV Technologies S.A (DBVT) France $1.166B 0.00
Zealand Pharma (ZEAL) Denmark $1.148B 0.00
Codexis (CDXS) United States $1.083B 0.00
Revance Therapeutics (RVNC) United States $1.033B 0.00
PHARMA MAR SA (PHMMF) Spain $1.025B 0.00
Sangamo Therapeutics (SGMO) United States $1.019B 0.00
Pharming Group (PHGUF) Netherlands $0.955B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.897B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.879B 0.00
Mesoblast (MESO) Australia $0.832B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.807B 6.78
Cellectis S.A (CLLS) France $0.785B 0.00
Twist Bioscience (TWST) United States $0.782B 0.00
GENFIT S.A (GNFT) France $0.775B 0.00
Heska (HSKA) United States $0.767B 195.98
Vericel (VCEL) United States $0.760B 283.33
Cytokineticsorporated (CYTK) United States $0.749B 0.00
Sorrento Therapeutics (SRNE) United States $0.732B 0.00
Adverum Biotechnologies (ADVM) United States $0.732B 0.00
Intellia Therapeutics (NTLA) United States $0.725B 0.00
ANI Pharmaceuticals (ANIP) United States $0.720B 12.28
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.713B 0.00
Retrophin (RTRX) United States $0.703B 0.00
Anika Therapeutics (ANIK) United States $0.682B 22.12
UROGEN PHARMA (URGN) United States $0.679B 0.00
Cara Therapeutics (CARA) United States $0.672B 0.00
AC Immune SA (ACIU) Switzerland $0.668B 15.45
Prothena (PRTA) Ireland $0.608B 0.00
Precision BioSciences (DTIL) United States $0.591B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.588B 0.00
Kadmon Holdings (KDMN) United States $0.558B 0.00
BioDelivery Sciences (BDSI) United States $0.522B 0.00
NantKwest (NK) United States $0.521B 0.00
Clovis Oncology (CLVS) United States $0.517B 0.00
Agenus (AGEN) United States $0.511B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.511B 0.00
Dynavax Technologies (DVAX) United States $0.481B 0.00
Bellus Health (BLU) Canada $0.480B 0.00
Arcus Biosciences (RCUS) United States $0.475B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.470B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.465B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.453B 3.13
Xenon Pharmaceuticals (XENE) Canada $0.438B 0.00
Pfenex (PFNX) United States $0.433B 0.00
AnaptysBio (ANAB) United States $0.421B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.420B 0.00
Kindred Biosciences (KIN) United States $0.406B 0.00
Gritstone Oncology (GRTS) United States $0.405B 0.00
Syros Pharmaceuticals (SYRS) United States $0.390B 0.00
PDL BioPharma (PDLI) United States $0.379B 9.49
Avid Bioservices (CDMO) United States $0.368B 0.00
Merus (MRUS) Netherlands $0.365B 0.00
Cue Biopharma (CUE) United States $0.365B 0.00
CytomX Therapeutics (CTMX) United States $0.355B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
Stemline Therapeutics (STML) United States $0.343B 0.00
Cellular Biomedicine (CBMG) United States $0.337B 0.00
Inovio Pharmaceuticals (INO) United States $0.335B 0.00
Cel-Sci (CVM) United States $0.328B 0.00
Puma Biotechnology (PBYI) United States $0.326B 0.00
Albireo Pharma (ALBO) United States $0.325B 0.00
VBI Vaccines (VBIV) United States $0.324B 0.00
Starpharma Holdings (SPHRY) Australia $0.314B 0.00
MannKind (MNKD) United States $0.314B 0.00
Geron (GERN) United States $0.298B 0.00
Compugen (CGEN) Israel $0.297B 0.00
Mersana Therapeutics (MRSN) United States $0.295B 0.00
IVERIC Bio (ISEE) United States $0.284B 0.00
WAVE Life Sciences (WVE) Singapore $0.273B 0.00
Sutro Biopharma (STRO) United States $0.272B 0.00
Prometic Life Sciences (LMNL) Canada $0.266B 0.00
ADMA Biologics Inc (ADMA) United States $0.261B 0.00
ChromaDex (CDXC) United States $0.261B 0.00
Kamada (KMDA) Israel $0.260B 7.60
OSMOTICA PHARM (OSMT) United States $0.257B 0.00
Biofrontera AG (BFRA) Germany $0.255B 0.00
Theratechnologies (THTX) Canada $0.235B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.235B 0.00
Seres Therapeutics (MCRB) United States $0.229B 0.00
Exicure (XCUR) United States $0.227B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.219B 0.00
Affimed (AFMD) Germany $0.217B 0.00
Cerecor (CERC) United States $0.216B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.215B 0.00
XOMA (XOMA) United States $0.210B 0.00
Athersys (ATHX) United States $0.204B 0.00
ARAVIVE, INC (ARAV) United States $0.198B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.195B 0.00
Protagonist Therapeutics (PTGX) United States $0.195B 0.00
Arbutus Biopharma (ABUS) Canada $0.191B 0.00
Alcobra (ARCT) United States $0.184B 0.00
Five Prime Therapeutics (FPRX) United States $0.181B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.179B 0.00
CorMedix Inc (CRMD) United States $0.178B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.176B 0.00
Spero Therapeutics (SPRO) United States $0.175B 0.00
Menlo Therapeutics (MNLO) United States $0.169B 0.00
Fortress Biotech (FBIO) United States $0.168B 0.00
TELA Bio (TELA) United States $0.167B 0.00
Palatin Technologies (PTN) United States $0.164B 4.46
Dyadic (DYAI) United States $0.153B 0.00
Verastem (VSTM) United States $0.152B 0.00
PHASEBIO PHARMA (PHAS) United States $0.152B 0.00
Applied Genetic Technologies (AGTC) United States $0.149B 0.00
Windtree Therapeutics (WINT) United States $0.145B 0.00
Selecta Biosciences (SELB) United States $0.142B 0.00
Novavax (NVAX) United States $0.141B 0.00
Abeona Therapeutics (ABEO) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.128B 0.00
Strongbridge Biopharma (SBBP) United States $0.125B 3.33
Arsanis (XFOR) United States $0.124B 0.00
VTv Therapeutics (VTVT) United States $0.123B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.123B 0.00
Enzo Biochem (ENZ) United States $0.122B 0.00
Aptinyx (APTX) United States $0.119B 0.00
Celyad SA (CYAD) Belgium $0.112B 0.00
Liquidia Technologies (LQDA) United States $0.111B 0.00
BioTime (LCTX) United States $0.110B 5.65
OvaScience (MLND) United States $0.108B 0.00
Clearside Biomedical (CLSD) United States $0.107B 0.00
Antibe Therapeutics (ATBPF) Canada $0.106B 0.00
SESEN BIO, INC (SESN) United States $0.104B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.103B 0.00
Acorda Therapeutics (ACOR) United States $0.102B 0.00
Synlogic (SYBX) United States $0.102B 0.00
Aduro Biotech (ADRO) United States $0.100B 0.00
Proteostasis Therapeutics (PTI) United States $0.096B 0.00
Emmaus Life Sciences (EMMA) United States $0.091B 0.00
AIT Therapeutics (XAIR) United States $0.089B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Trevena (TRVN) United States $0.082B 0.00
Prima BioMed (IMMP) Australia $0.080B 0.00
Orgenesis (ORGS) United States $0.080B 5.18
Catabasis Pharmaceuticals (CATB) United States $0.080B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
NewLink Genetics (NLNK) United States $0.074B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Checkpoint Therapeutics (CKPT) United States $0.065B 0.00
Pluristem Therapeutics (PSTI) Israel $0.064B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Curis (CRIS) United States $0.056B 0.00
Idera Pharmaceuticals (IDRA) United States $0.055B 0.00
Protalix BioTherapeutics (PLX) Israel $0.054B 0.00
AquaBounty Technologies (AQB) United States $0.052B 0.00
DiaMedica Therapeutics (DMAC) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.050B 0.00
Evogene (EVGN) Israel $0.045B 0.00
Celldex Therapeutics (CLDX) United States $0.040B 0.00
CollPlant Holdings (CLGN) Israel $0.039B 0.00
BioCardia (BCDA) United States $0.037B 0.00
Soligenix (SNGX) United States $0.037B 0.00
Celsion (CLSN) United States $0.037B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Entera Bio (ENTX) Israel $0.032B 0.00
Bionano Genomics (BNGO) United States $0.031B 0.00
Pulmatrix (PULM) United States $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
VIVUS (VVUS) United States $0.029B 0.00
AmpliPhi Biosciences (ARMP) United States $0.029B 0.00
Unum Therapeutics (UMRX) United States $0.029B 0.00
Novogen (KZIA) Australia $0.028B 0.00
Stellar Biotechnologies (EDSA) Canada $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Oncobiologics (OTLK) United States $0.024B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Advaxis (ADXS) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
Cesca Therapeutics (THMO) United States $0.013B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Cleveland BioLabs (CBLI) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
IBio (IBIO) United States $0.007B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.005B 0.00